Hemorrhagic Shock
Conditions
Keywords
Blood transfusion, Pre-hospital care
Brief summary
The primary aim of this observational registry is to study the outcomes of patients with hemorrhagic shock transported by Boston MedFlight receiving blood products during transport.
Detailed description
Boston MedFlight, a critical care transport organization, based on a consortium of the academic medical centers in Boston, will begin carrying PRBC in 2019. The program is intended to provide BMF clinicians with 24-hour immediate access to appropriate blood products to be utilized if needed for patients following life-threatening illness or injury. The four fundamental goals of this program are: save lives' ensure transfusion safety; minimize blood product waste; and conduct continuous quality assurance. Our goal is to observationally evaluate this new protocol of administering blood products in the pre-hospital setting. We will collect data on patients with hemorrhagic shock being transported by Boston MedFlight, who receive or would have been eligible to receive pre-hospital blood transfusion by the inclusion criteria.
Interventions
None listed
Sponsors
Boston MedFlight
Boston Medical Center
Tufts Medical Center
Lahey Clinic
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients who would be eligible to receive blood products; * systolic blood pressure \<90 mmHg * a shock index of \> 0.9 * clinical signs of shock as determined by the transport clinicians.
Exclusion criteria
* Age \< 18 years old
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 30-day mortality | 30 days | 30-day all cause mortality |
Countries
United States
Contacts
Primary ContactAngela Renne
Outcome results
None listed